Transplantation, AutologousHematopoietic Stem Cell TransplantationTransplantation, HomologousBone Marrow TransplantationLiver TransplantationTransplantation ConditioningStem Cell TransplantationMultiple MyelomaHematopoietic Stem CellsKidney TransplantationHematopoietic Stem Cell MobilizationAntigens, CD34MelphalanGraft SurvivalStem CellsPeripheral Blood Stem Cell TransplantationTreatment OutcomeCell TransplantationCombined Modality TherapyLymphoma, Non-HodgkinHeart TransplantationGranulocyte Colony-Stimulating FactorBone Marrow PurgingLeukapheresisSalvage TherapyLung TransplantationCarmustineRecurrenceCyclophosphamideWhole-Body IrradiationGraft vs Host DiseaseAntineoplastic Combined Chemotherapy ProtocolsCell DifferentiationRemission InductionTime FactorsBone Marrow CellsDisease-Free SurvivalColony-Forming Units AssayOrgan TransplantationEtoposideRetrospective StudiesSurvival AnalysisCells, CulturedHematopoiesisBone MarrowBusulfanHodgkin DiseaseHematologic NeoplasmsBlood Transfusion, AutologousGraft RejectionImmunosuppressive AgentsSurvival RateCytarabinePancreas TransplantationTissue DonorsIslets of Langerhans TransplantationCell SeparationTransplantation ImmunologyFollow-Up StudiesTransplantationGraft vs Tumor EffectTransplantation ChimeraMyeloablative AgonistsBlood Component RemovalKanamycin KinaseThalidomideFlow CytometryCell LineageFeasibility StudiesCell Culture TechniquesTransplantation, IsogeneicBlood Cell CountVincristinePrognosisGenetic TherapyLymphomaMyeloid Progenitor CellsCord Blood Stem Cell TransplantationAntigens, CDNeoplasm, ResidualLeukemiaLeukemia, Myeloid, AcuteTransplantation, HeterotopicImmunomagnetic SeparationLiving DonorsTransduction, GeneticIdarubicinGenetic VectorsAntineoplastic Agents, AlkylatingMyelodysplastic SyndromesPrednisoneDexamethasoneLentivirusHeart-Lung TransplantationMice, Inbred C57BLProspective StudiesAntibodies, MonoclonalImmunosuppressionFetal Tissue TransplantationTissue and Organ Procurement